西格列汀联合地特胰岛素治疗老年2型糖尿病的疗效研究

目的格列汀联合地特胰岛素治疗老年2型糖尿病的疗效研究。方法择在该院进行2型糖尿病治疗的68例老年患者进行调查,选取时间为2018年2月-2019年1月。将患者分为两组,每组34例。对比组采用常规治疗方式,实验组采用了西格列汀联合地特胰岛素治疗方式。分析两组最终的治疗结果。结果对比组患者胰岛素使用剂量和实验组相比较高,差异有统计学意义(P<0.05);对比组HbAlc水平、2 hPG水平、FBG水平和实验组相比较高,差异有统计学意义(P<0.05)。结论老年2型糖尿病治疗中,可采取西格列汀联合地特胰岛素治疗方式,效果优异。

Efficacy of Sitagliptin Combined with Detemir in the Treatment of Type 2 Diabetes in the Elderly

Objective The efficacy of glitatine combined with insulin detemir in the treatment of type 2 diabetes in the elderly. Methods A total of 68 elderly patients undergoing type 2 diabetes treatment in the hospital were selected for investigation, and the selection time was 2018.2-2019.1. Patients were divided into 2 groups of 34 patients each. The comparison group was treated with conventional treatment, and the experimental group was treated with sitagliptin combined with insulin detemir. The final treatment results of the two groups were analyzed. Results Compared with the experimental group, the dosage of insulin in the patients in the comparison group was higher than that in the experimental group, with a statistically significant difference(P<0.05);the HbAlc level, 2 hPG level, and FBG level in the comparison group were higher than those in the experimental group, with statistically significant differences(P<0.05). Conclusion In the treatment of elderly patients with type 2 diabetes, sitagliptin combined with insulin detemir can be used. The effect is excellent and it is worthy of application.